Nov 23 2013
The spin-off from Joseph Fourier University, Grenoble (UJF), starts its incubation period accompanied by Grenoble’s innovation accelerators, Gravit and GATE1. Based on research by its leader, Prof. Jean Viallet (Associate Professor at UJF), the team intends to develop very promising in vivo assays for drug development, particularly for cancer treatments
Apr 8-13
2022
INOVOTION WILL ATTEND THE AACR
Join us at AACR 2022 in New Orleans, April 8 -13! Stop by our Booth #3315 to learn more about our new, efficient, 3R-compliant and cost-effective preclinical models! Meet with Philippe Fornies, our […]
Mar 8
2022
INTERNATIONAL WOMEN'S RIGHTS DAY
Gender Equality at Inovotion. On this International Women’s Rights Day, we have chosen to highlight the women at Inovotion who contribute every day to ensuring a better world: a future without cancer. Each […]
Mar 2
2022
INOVOTION EXPANDS ITS BUSINESS DEVELOPMENT TEAM
Earl Morrison joins INOVOTION’s Business Team! Earl has a 30 years’ experience in preclinical research and a deep knowledge of the West Coast biopharma environment. He brings unique talents to Inovotion’s Business Development team! […]
